
Sign up to save your podcasts
Or


In a recent study, investigators conducted a randomized trial to compare the efficacy and tolerability of a fixed dose of an oral chemotherapy drug on a 7/7 schedule. Here with Dr. Pavani Chalasani to discuss the results from the X-7/7 trial is Dr. Colleen Bohnenkamp, Oncology Clinical Pharmacist who specializes in women’s cancers at the University of Kansas Cancer Center.
By ReachMD4.5
22 ratings
In a recent study, investigators conducted a randomized trial to compare the efficacy and tolerability of a fixed dose of an oral chemotherapy drug on a 7/7 schedule. Here with Dr. Pavani Chalasani to discuss the results from the X-7/7 trial is Dr. Colleen Bohnenkamp, Oncology Clinical Pharmacist who specializes in women’s cancers at the University of Kansas Cancer Center.

39 Listeners

10 Listeners

59 Listeners

1,148 Listeners

195 Listeners

45 Listeners

7 Listeners